Skip to content

Epilepsy rhythm markers and chronotherapy

Epilepsy rhythm markers and chronotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084486
Enrollment
Unknown
Registered
2024-05-17
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Chronological treatment group:Administer different doses of sodium valproate in the morning and evening, respectively
Conventional treatment group:Administer the same dose of sodium valproate in the morning and evening separately

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Volunteers voluntarily cooperate with the study and sign an informed consent form. ? Subjects diagnosed with JME, BECTs, or frontal lobe epilepsy according to guideline criteria ? Epilepsy subjects who require hospitalization or monitoring for seizures; ? Age range from 5 to 60 years old, half male and half female; ? The type and dosage of antiepileptic drugs did not change during the experiment, ? Participants or their families refuse invasive treatment, such as surgery.

Exclusion criteria

Exclusion criteria: ? Suffering from intellectual disabilities, organic brain injury, or epileptic seizures. ? Participants in a state of persistent epilepsy, ? Participants with severe infections, cerebrovascular diseases, malignant tumors and other neurological diseases, severe dysfunction of organs such as the heart, liver, and kidneys, and mental disorders, ? Participants diagnosed with syncope, hysteria, or other non epileptic seizures, ? Pregnant or lactating participants, ? The patient has contraindications for repeated transcranial magnetic stimulation.

Design outcomes

Primary

MeasureTime frame
The proportion of epilepsy without seizures;

Secondary

MeasureTime frame
Treatment retention time;Drug dosage levels without seizures;Adverse reaction incidence rate;

Countries

China

Contacts

Public ContactLisen Sui

Guangdong Provincial Hospital of Traditional Chinese Medicine

13711580891@163.com+86 137 1158 0891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026